J.W. Cole Advisors Inc. Acquires 156,524 Shares of Tilray Inc (NASDAQ:TLRY)

J.W. Cole Advisors Inc. increased its holdings in shares of Tilray Inc (NASDAQ:TLRY) by 1,077.2% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 171,054 shares of the company’s stock after acquiring an additional 156,524 shares during the period. J.W. Cole Advisors Inc.’s holdings in Tilray were worth $284,000 at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the business. Lazard Asset Management LLC bought a new position in Tilray in the 1st quarter valued at $118,000. Avantax Advisory Services Inc. boosted its position in Tilray by 46.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock valued at $131,000 after buying an additional 16,792 shares during the last quarter. Concurrent Investment Advisors LLC bought a new position in Tilray in the 1st quarter valued at $75,000. CIBC Asset Management Inc boosted its position in Tilray by 13.3% in the 2nd quarter. CIBC Asset Management Inc now owns 871,299 shares of the company’s stock valued at $1,445,000 after buying an additional 102,316 shares during the last quarter. Finally, Austin Wealth Management LLC bought a new position in Tilray in the 4th quarter valued at $115,000. 9.35% of the stock is currently owned by institutional investors.

Tilray Stock Down 0.6 %

Shares of TLRY opened at $1.80 on Thursday. Tilray Inc has a 52 week low of $1.50 and a 52 week high of $2.97. The company has a current ratio of 2.27, a quick ratio of 1.42 and a debt-to-equity ratio of 0.10. The business’s fifty day moving average price is $1.82 and its two-hundred day moving average price is $1.87.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Monday, July 29th. The company reported ($0.04) EPS for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.15) EPS. As a group, equities analysts forecast that Tilray Inc will post -0.16 EPS for the current year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.